107 related articles for article (PubMed ID: 25270213)
21. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological analysis of pleomorphic carcinoma of the lung: diffuse ZEB1 expression predicts poor survival.
Miyahara S; Hamasaki M; Hamatake D; Yamashita S; Shiraishi T; Iwasaki A; Nabeshima K
Lung Cancer; 2015 Jan; 87(1):39-44. PubMed ID: 25479687
[TBL] [Abstract][Full Text] [Related]
23. Expression of classic cadherins type I in urothelial neoplastic progression.
Rieger-Christ KM; Cain JW; Braasch JW; Dugan JM; Silverman ML; Bouyounes B; Libertino JA; Summerhayes IC
Hum Pathol; 2001 Jan; 32(1):18-23. PubMed ID: 11172290
[TBL] [Abstract][Full Text] [Related]
24. Altered expression of cell adhesion molecules leads to differential uptake of hypericin in urothelial cancer.
Olivo M; Lucky SS; Kent Mancer JF; Lau WK
Urol Oncol; 2012 Sep; 30(5):624-34. PubMed ID: 20933443
[TBL] [Abstract][Full Text] [Related]
25. Expression and predictive value of lymph-specific markers in urothelial carcinoma of the bladder.
von Hardenberg J; Martini T; Knauer A; Ströbel P; Becker A; Herrmann E; Schubert C; Steidler A; Bolenz C
Urol Oncol; 2014 Jan; 32(1):54.e9-17. PubMed ID: 24360666
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of survivin, β-catenin and p53 expression in urothelial carcinoma.
Senol S; Yildirim A; Ceyran B; Uruc F; Zemheri E; Ozkanli S; Akalin I; Ulus I; Caskurlu T; Aydin A
Bosn J Basic Med Sci; 2015 Aug; 15(4):7-14. PubMed ID: 26614845
[TBL] [Abstract][Full Text] [Related]
27. [Expression of cyclooxygenase-2 in bladder transitional cell carcinoma and the significance thereof].
Yu L; Chen XJ; Shi PQ; Ding Q; Sun CH; Liu GB; Shi DM; Huang YG
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(38):2683-4. PubMed ID: 19080686
[TBL] [Abstract][Full Text] [Related]
28. [Expression and clinical significance of 5hmC in bladder urothelial carcinoma].
Li J; Xu Y; Zhang Z; Zhang M; Zhang Z; Zhang F; Li Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):232-5. PubMed ID: 26927384
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of NANOG in urothelial carcinoma of the bladder.
Md Akhir MKA; Hussin H; Veerakumarasivam A; Choy CS; Abdullah MA; Abd Ghani F
Malays J Pathol; 2017 Dec; 39(3):227-234. PubMed ID: 29279584
[TBL] [Abstract][Full Text] [Related]
31. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
32. [p16, p53 and c-erbB-2 gene expression in bladder carcinoma].
Wang C; Liu X; Wang L; Chen D; Tan Z; Wang Z; Chen T
Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):20-3. PubMed ID: 11866886
[TBL] [Abstract][Full Text] [Related]
33. Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder.
Bi J; Chen X; Zhang Y; Li B; Sun J; Shen H; Kong C
Urol Oncol; 2012 Sep; 30(5):688-94. PubMed ID: 20888270
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of lactate/proton symporters MCT1, MCT4, and their chaperone CD147 expressions in urothelial carcinoma of the bladder.
Choi JW; Kim Y; Lee JH; Kim YS
Urology; 2014 Jul; 84(1):245.e9-15. PubMed ID: 24857275
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of E-cadherin, alpha-, beta- and gamma-catenin in bladder cancer patients who underwent radical cystectomy.
Kashibuchi K; Tomita K; Schalken JA; Kume H; Takeuchi T; Kitamura T
Int J Urol; 2007 Sep; 14(9):789-94. PubMed ID: 17760743
[TBL] [Abstract][Full Text] [Related]
37. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
[TBL] [Abstract][Full Text] [Related]
38. The prognostic value of E-cadherin, alpha-, beta-, and gamma-catenin in urothelial cancer of the upper urinary tract.
Kashibuchi K; Tomita K; Schalken JA; Kume H; Yamaguchi T; Muto S; Horie S; Kitamura T
Eur Urol; 2006 May; 49(5):839-45; discussion 845. PubMed ID: 16426728
[TBL] [Abstract][Full Text] [Related]
39. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
Zhou JT; Cai ZM; Li NC; Na YQ
Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
[TBL] [Abstract][Full Text] [Related]
40. ZEB1 expression in endometrial biopsy predicts lymph node metastases in patient with endometrial cancer.
Feng G; Wang X; Cao X; Shen L; Zhu J
Dis Markers; 2014; 2014():680361. PubMed ID: 25544793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
